Cargando…

Serum Biomarkers in Carotid Artery Disease

Carotid artery disease is considered a major cause of strokes and there is a need for early disease detection and management. Although imaging techniques have been developed for the diagnosis of carotid artery disease and different imaging-based markers have been proposed for the characterization of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kigka, Vassiliki I., Potsika, Vassiliki, Mantzaris, Michalis, Tsakanikas, Vassilis, Koncar, Igor, Fotiadis, Dimitrios I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619296/
https://www.ncbi.nlm.nih.gov/pubmed/34829489
http://dx.doi.org/10.3390/diagnostics11112143
_version_ 1784604956648538112
author Kigka, Vassiliki I.
Potsika, Vassiliki
Mantzaris, Michalis
Tsakanikas, Vassilis
Koncar, Igor
Fotiadis, Dimitrios I.
author_facet Kigka, Vassiliki I.
Potsika, Vassiliki
Mantzaris, Michalis
Tsakanikas, Vassilis
Koncar, Igor
Fotiadis, Dimitrios I.
author_sort Kigka, Vassiliki I.
collection PubMed
description Carotid artery disease is considered a major cause of strokes and there is a need for early disease detection and management. Although imaging techniques have been developed for the diagnosis of carotid artery disease and different imaging-based markers have been proposed for the characterization of atherosclerotic plaques, there is still need for a definition of high-risk plaques in asymptomatic patients who may benefit from surgical intervention. Measurement of circulating biomarkers is a promising method to assist in patient-specific disease management, but the lack of robust clinical evidence limits their use as a standard of care. The purpose of this review paper is to present circulating biomarkers related to carotid artery diagnosis and prognosis, which are mainly provided by statistical-based clinical studies. The result of our investigation showed that typical well-established inflammatory biomarkers and biomarkers related to patient lipid profiles are associated with carotid artery disease. In addition to this, more specialized types of biomarkers, such as endothelial and cell adhesion, matrix degrading, and metabolic biomarkers seem to be associated with different carotid artery disease outputs, assisting vascular specialists in selecting patients at high risk for stroke and in need of intervention.
format Online
Article
Text
id pubmed-8619296
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86192962021-11-27 Serum Biomarkers in Carotid Artery Disease Kigka, Vassiliki I. Potsika, Vassiliki Mantzaris, Michalis Tsakanikas, Vassilis Koncar, Igor Fotiadis, Dimitrios I. Diagnostics (Basel) Review Carotid artery disease is considered a major cause of strokes and there is a need for early disease detection and management. Although imaging techniques have been developed for the diagnosis of carotid artery disease and different imaging-based markers have been proposed for the characterization of atherosclerotic plaques, there is still need for a definition of high-risk plaques in asymptomatic patients who may benefit from surgical intervention. Measurement of circulating biomarkers is a promising method to assist in patient-specific disease management, but the lack of robust clinical evidence limits their use as a standard of care. The purpose of this review paper is to present circulating biomarkers related to carotid artery diagnosis and prognosis, which are mainly provided by statistical-based clinical studies. The result of our investigation showed that typical well-established inflammatory biomarkers and biomarkers related to patient lipid profiles are associated with carotid artery disease. In addition to this, more specialized types of biomarkers, such as endothelial and cell adhesion, matrix degrading, and metabolic biomarkers seem to be associated with different carotid artery disease outputs, assisting vascular specialists in selecting patients at high risk for stroke and in need of intervention. MDPI 2021-11-18 /pmc/articles/PMC8619296/ /pubmed/34829489 http://dx.doi.org/10.3390/diagnostics11112143 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kigka, Vassiliki I.
Potsika, Vassiliki
Mantzaris, Michalis
Tsakanikas, Vassilis
Koncar, Igor
Fotiadis, Dimitrios I.
Serum Biomarkers in Carotid Artery Disease
title Serum Biomarkers in Carotid Artery Disease
title_full Serum Biomarkers in Carotid Artery Disease
title_fullStr Serum Biomarkers in Carotid Artery Disease
title_full_unstemmed Serum Biomarkers in Carotid Artery Disease
title_short Serum Biomarkers in Carotid Artery Disease
title_sort serum biomarkers in carotid artery disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619296/
https://www.ncbi.nlm.nih.gov/pubmed/34829489
http://dx.doi.org/10.3390/diagnostics11112143
work_keys_str_mv AT kigkavassilikii serumbiomarkersincarotidarterydisease
AT potsikavassiliki serumbiomarkersincarotidarterydisease
AT mantzarismichalis serumbiomarkersincarotidarterydisease
AT tsakanikasvassilis serumbiomarkersincarotidarterydisease
AT koncarigor serumbiomarkersincarotidarterydisease
AT fotiadisdimitriosi serumbiomarkersincarotidarterydisease